Obermatt
See Similar Stocks →

Hyperliquid Strategies

NAQ:PURR · US44916Y1064
BiotechnologyX-Small

360° View

no current rank
Price/Sales6
Price/Earnings100
Price/Book—
Dividend Yield1
Revenue Growth98
Profit Growth—
Capital Growth—
TSR 52w88
Leverage91
Liquidity—
Refinancing—
Combined—
Analyst Opinions69
Pro Holdings33
Opinion Changes50
Market Pulse7

Profile

CountryUSA
IndustryBiotechnology
SizeX-Small
TypePublic Company
ExchangeNASDAQCM
Founded2025
ISINUS44916Y1064
Last UpdateApr 2, 2026
Index & Theme
FintechCryptocurrencyDecentralized FinanceBlockchainVirtual CurrencyWeb3

Description

Similar Stocks

The companies this stock is ranked against.

Compare Hyperliquid Strategies with its peers
Corbus Pharmaceuticals Holdings
NAQ:CRBP
62
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Figure Technology Solutions
NSQ:FIGR
18
CountryUSA
IndustryConsumer Finance
SizeSmall
Full Stock Analysis →
Myriad Genetics
NSQ:MYGN
12
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Enanta Pharmaceuticals
NSQ:ENTA
62
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Xeris Pharmaceuticals
NSQ:XERS
70
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Rigetti Computing
NAQ:RGTI
5
CountryUSA
IndustrySemiconductors & Semiconductor Equipment
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →